Literature DB >> 28452390

Benzodiazines: recent synthetic advances.

Thomas Mathew1, Attila Á Papp, Farzaneh Paknia, Santos Fustero, G K Surya Prakash.   

Abstract

Benzodiazines (diazonaphthalenes with both nitrogens in the same ring) - cinnolines (1,2-benzodiazine), quinazolines (1,3-benzodiazine), phthalazines (2,3-benzodiazine) and quinoxalines (1,4-benzodiazine) - are important class of compounds with broad biological properties and wide application in pharmaceutical as well as agrochemical arenas. These diazaheterocycles are present in a wide variety of bioactive natural products as well as synthetic molecules that are good drug candidates constituting key structural units responsible for their pronounced therapeutic activities. Their rapidly growing uses and applications in medicinal and agrochemical arenas prompt the researchers for further studies on this important group of compounds. In this review, we hope to provide a brief overview of the important general methodologies and recent developments towards their synthesis and open the door for further progress in this area.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28452390     DOI: 10.1039/c7cs00082k

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  3 in total

Review 1.  Montmorillonite clay-based heterogenous catalyst for the synthesis of nitrogen heterocycle organic moieties: a review.

Authors:  Thangapandi Chellapandi; Gunabalan Madhumitha
Journal:  Mol Divers       Date:  2021-10-27       Impact factor: 3.364

2.  DMAP-Catalyzed One-Pot Synthesis of Quinazoline-2,4-diones from 2-Aminobenzamides and Di-tert-butyl Dicarbonate.

Authors:  Hui Chen; Peng Li; Rongfei Qin; Hong Yan; Gang Li; Haihong Huang
Journal:  ACS Omega       Date:  2020-04-16

3.  PIDA-mediated intramolecular oxidative C-N bond formation for the direct synthesis of quinoxalines from enaminones.

Authors:  Hong Zhang; Jinhai Shen; Zhenhui Yang; Xiuling Cui
Journal:  RSC Adv       Date:  2019-03-07       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.